(Q46782906)

25 December 2017

title

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer (English)

1 reference

25 December 2017

1 reference

Janice L Berliner

1

1 reference

25 December 2017

Angela Musial Fay

2

1 reference

25 December 2017

Shelly A Cummings

3

1 reference

25 December 2017

Brittany Burnett

4

1 reference

25 December 2017

Todd Tillmanns

5

1 reference

25 December 2017

publication date

28 November 2012

1 reference

25 December 2017

Journal of Genetic Counseling

published in

1 reference

25 December 2017

volume

22

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

155-163

1 reference

25 December 2017

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Assessing the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Variation of breast cancer risk among BRCA1/2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Banning genetic discrimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

The Icelandic founder mutation BRCA2 999del5: analysis of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Rapid progression of prostate cancer in men with a BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Genetic counseling and clinical cancer genetics services

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9547-1

Hereditary breast and ovarian cancer syndrome

21 January 2018

1 reference

12 December 2020

High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history

1 reference

12 December 2020

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

12 December 2020

An explication of the National Society of Genetic Counselors (NSGC) code of ethics

1 reference

12 December 2020

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis

1 reference

12 December 2020

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

1 reference

12 December 2020

Points to consider in the clinical application of genomic sequencing

1 reference

12 December 2020

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome

1 reference

12 December 2020

BRCA germline mutations in women with uterine serous carcinoma--still a debate

1 reference

12 December 2020

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1 reference

12 December 2020

10.1007/S10897-012-9547-1

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

23188549

1 reference

25 December 2017